Furthermore, according to Feng et al. [127], AR activation would lead to greater transcription of the cell cycle-related kinase (CCRK) regulator, a critical mediator of AR signaling that appears markedly increased in HCC. The gene discussed is AR; the disease is hepatocellular carcinoma.